Jump to Navigation
Deciphera

Secondary Menu

  • Home
  • Partners
  • News
  • Contact

News

News

  • 06.24.2011
    Deciphera Pharmaceuticals launches its updated website.
    Read More
  • 04.02.2011
    FMS Kinase inhibitor DCC-2909 presented at AACR in Orlando FL.
    Read More
  • 02.01.2011
    Deciphera Pharmaceuticals moves to its new facility in Lawrence, KS.
    Read More

Archives

Press Releases

  • 02.01.2012
    Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company
    Read More
  • 07.18.2011
    Kansas Biosciences Authority Votes in Favor of a $1.6MM Product Development Grant to Deciphera.
    Read More
  • 07.06.2011
    Deciphera Pharmaceuticals and the University of Kansas Cancer Center team up for clinical study of leukemia drug
    Read More

Archives

Main menu

  • About Us
  • Technology
  • Pipeline
  • Clinical Trials

Media Kit

Featured Presentation

01.2011

“Kinase Inhibitor Platform, High Level Pipeline Summaries and Partnering Opportunities.” Biotech Showcase, San Francisco, CA 2011.

More Presentations

Featured Publication

04.2011

“Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036”, Cancer Cell, Volume 19, Issue 4, 556-568, April 2011

More Publications

© 2011 Deciphera Pharmaceuticals, LLC. All Rights Reserved. Site by BOLD.